Placebo-controlled trials with COVID-19 vaccines: participants first.

Dal-Ré, Rafael

Dal-Ré, Rafael.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: rafael.dalre@quironsalud.es.

J Clin Epidemiol ; 138: 211-212, 2021 10.

Article in English | MEDLINE | ID: covidwho-1309275

Subject(s)

COVID-19 Vaccines/administration & dosage; Randomized Controlled Trials as Topic/methods; COVID-19/epidemiology; COVID-19/prevention & control; Humans; Placebos; Research Design; Risk Assessment

Keywords

COVID-19; Conditional marketing authorization; Emergency use authorization; Placebo-controlled trials; SARS-CoV-2; Vaccines; Withdrawal

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / COVID-19 Vaccines Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: J Clin Epidemiol Journal subject: Epidemiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google